U.S., March 17 -- ClinicalTrials.gov registry received information related to the study (NCT07475286) titled 'Combined Systemic and Intraperitoneal Chemotherapy for Synchronous Gastric and/or Gastroesophageal Peritoneal Carcinomatosis' on March 09.
Brief Summary: This trial will administer laparoscopic hyperthermic intraperitoneal chemotherapy (HIPEC) to patients with peritoneal carcinomatosis from gastric cancer (GPC) who are receiving standard of care systemic chemotherapy.
Study Start Date: April 30
Study Type: INTERVENTIONAL
Condition:
Synchronous Gastric Peritoneal Carcinomatosis
Gastroesophageal Peritoneal Carcinomatosis
Intervention:
DRUG: Cisplatin
Cisplatin interferes with DNA replication, which kills the fastest proliferat...